Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD

NCT02168127 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

360

Enrollment

INDUSTRY

Sponsor class

Conditions

ADHD

Interventions

DRUG: Drug: PRC-063
DRUG: PRC-063

Sponsor

Rhodes Pharmaceuticals, L.P.

Collaborators

[object Object]